Phase I trial of bromopyruvate (PSL-001) in patients with primary and/or metastatic liver cancer.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2013
Price : $35 *
At a glance
- Drugs Bromopyruvate (Primary)
- Indications Liver cancer; Liver metastases
- Focus Adverse reactions
- 25 Jul 2013 New trial record
- 24 Jul 2013 The US FDA has approved the IND application for phase I clinical evaluation of bromopyruvate and this trial is expected to be initiated in early 2014, according to a PreScience Labs media release.